JAZZ: Jazz Pharmaceuticals plc
Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness - PR Newswire
Good trading week. I have not closed any position yet as you guys know i don't trade lower time frames. Some good opportunities came this week. Let's take a look at jazz which i bought today.
Monthly is nice chart with kijun sen holding firmly. Macd is above zero but trying to cross up but won't be confirmed till the end of the month.
Weekly is again bullish...
As the entire Pharma sector seems to be moving higher, JAZZ appears ready to join in. Finding support at the 75sma it is now moving away from it higher. Watch the double top, a break above that would be bullish. IMHO
JAZZ has completed a textbook A-B-C correction bottoming out at 95.80 in Nov 2016.
Sharp reversal at 50% fib retracement is good sign.
2W RSI and MACD divergence is a significant supporting evidence of the upturn.
Look for an initial target of its previous high of 194.
Critical support at Minuette Wave C at 95.80.
Break of this low will invalidate the trade.
Strong channel downtrend since Aug 2015, with RSI overbought at ideal short entry levels (small green squares). RSI at overbought level again; signal to short in this case with harmonic period of about 6 months.
Also current small double top at about $130 mark (short orange); stock expected to close gap to about $118 for initial target short-term target. That...
Yesterday's price action brings more questions to the strengths of recent breakout from July's high. Trend is up and strong but may soon come to end. Very volatile stock and price can go either way. Price appreciated almost 35% from August low, its very impressive but it may come to an halt. If price does not hold at D-level expect profit taking and shorts will be...